呼吸道感染治疗市场规模预计将从 2023 年的 436 亿美元增至 2031 年的 691.3 亿美元;预计 2023-2031 年期间的复合年增长率为 5.93%。
呼吸道感染(RTI)是指鼻窦、咽喉、气道或肺部的感染。全球呼吸道感染治疗市场报告强调了推动市场发展的关键因素,并描述了主要参与者的发展情况。推动市场增长的关键因素包括全球呼吸道感染患病率的上升、对呼吸道感染和各种呼吸道感染治疗方法的认识不断提高,以及与呼吸道感染治疗相关的临床试验数量不断增加。然而,缺乏针对呼吸治疗的研究和与呼吸道感染药物相关的不良反应阻碍了市场的增长。此外,抗病毒治疗的出现预计将在未来几年带来新的全球呼吸道感染治疗市场趋势。
增长动力和限制因素:
老年人口对呼吸系统疾病诊断的需求不断增加
随着全球老年人口的增长,预计未来几年对呼吸系统疾病诊断的需求将会增加。例如,根据 2021 年 11 月《英国药理学杂志》发表的一篇文章,英国每年约有 1% 的人口被诊断出患有社区获得性肺炎 (CAP)。约 70% 的病例发生在 65 岁以上的人群中,该年龄组的 30 天死亡率约为 20%。因此,老龄化人口的增加和 CAP 等疾病发病率的增加预计将推动对呼吸系统疾病治疗的需求,从而促进整体市场增长。
该领域的持续研究和开发已产生各种诊断测试和程序,这些测试和程序将对未来几年的市场增长产生积极影响。创新的诊断方法预计将在预测期内为市场发展提供良好的机会。然而,研究的缺乏和与呼吸道感染药物相关的不良反应预计将限制全球呼吸道感染治疗市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围:
全球呼吸道感染治疗市场分析考虑了以下细分市场:药物疾病适应症、给药途径、年龄组和分销渠道。基于药物,市场分为抗生素、非甾体抗炎药、止咳药、鼻减充血剂和其他。根据疾病适应症,全球呼吸道感染治疗市场细分为上呼吸道感染和下呼吸道感染。在给药途径方面,市场分为口服和肠外给药。根据年龄组,市场分为儿科和成人。根据分销渠道,全球呼吸道感染治疗市场细分为医院药房、网上药房和零售药房。
节段分析:
在药物方面,抗生素领域在 2023 年占据了全球呼吸道感染治疗市场的最大份额。预计该领域在 2023-2031 年期间的复合年增长率最高。呼吸道感染包括一系列疾病,包括支气管炎、肺炎和鼻窦炎,通常由细菌病原体引起。抗生素可以针对并消灭这些有害细菌,减少炎症并促进更快康复。用于治疗呼吸道感染的常用抗生素包括青霉素、头孢菌素、大环内酯类、氟喹诺酮类和四环素类,每种抗生素都有独特的作用机制和细菌靶标。
根据疾病指征,下呼吸道感染部分在 2023 年占据了更大的市场份额。预计 2023 年至 2031 年的复合年增长率将更高。下呼吸道感染 (LRTI) 是影响肺部和支气管的感染,通常由细菌、病毒或真菌病原体等引起。肺炎、支气管炎和细支气管炎等疾病通常表现出咳嗽、胸部不适、呼吸急促和发烧等症状,属于 LRTI 范畴。肺炎是一种严重的 LRTI,涉及肺组织的炎症和感染,导致肺实变(肺部的某些区域或整个器官)和气体交换受损。
按给药途径划分,口服药物在全球呼吸道感染治疗市场中占有较大份额;预计该领域在 2023-2031 年期间的复合年增长率将更高。口服抗生素(如阿莫西林、阿奇霉素或强力霉素)通常用于对抗引起呼吸道感染的细菌病原体。除了抗生素外,口服皮质类固醇还可以减轻严重哮喘或慢性阻塞性肺病 (COPD) 加重期的炎症。口服抗病毒药物(如奥司他韦)用于治疗病毒性呼吸道感染(如流感)。口服途径的共同优势包括给药方便、患者依从性和全身药物分布。
从年龄组来看,2023 年成人市场在全球呼吸道感染治疗市场中占据较大份额。儿科市场预计在 2023-2031 年期间将实现更高的复合年增长率。人们越来越意识到早期诊断和治疗儿童呼吸道感染的重要性,以及用于治疗的呼吸设备的进步,这些因素正在推动开发新的、更有效的治疗方案。此外,对预防性医疗保健的日益关注也促进了儿科市场的增长。
在分销渠道方面,预计医院药房将在 2023-2031 年期间占据相当大的市场份额。医院药房是医疗保健系统的重要组成部分;它们在管理需要静脉或肌肉注射药物的急性和严重呼吸道感染方面发挥着至关重要的作用。这些药房负责采购、储存和分发抗生素、抗病毒药物、皮质类固醇和其他呼吸道感染治疗药物,并确保它们安全及时地送达医院的住院和门诊。
呼吸道感染治疗市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响呼吸道感染治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的呼吸道感染治疗市场细分和地理位置。
- 获取呼吸道感染治疗市场的区域特定数据
呼吸道感染治疗市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 436亿美元 |
2031 年市场规模 | 691.3亿美元 |
全球复合年增长率(2023 - 2031) | 5.93% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按药物分类
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
呼吸道感染治疗市场参与者密度:了解其对业务动态的影响
呼吸道感染治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在呼吸道感染治疗市场运营的主要公司有:
- 雅培,
- 阿斯特拉捷利康,
- 西普拉,
- 默克公司
- 葛兰素史克公司
- 诺华公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解呼吸道感染治疗市场的主要参与者概况
区域分析:
人们越来越意识到早期诊断和治疗呼吸道感染的重要性,这可能会在未来几年促进全球呼吸道感染治疗市场的增长。市场分为北美、欧洲、亚太、中东和非洲以及南美和中美。2023 年,北美占据了全球最大的呼吸道感染治疗市场份额。由于北美呼吸道感染的患病率上升,北美市场正在经历显着增长。空气污染、吸烟和拥挤的生活条件等因素导致该国呼吸道感染发病率高。呼吸道感染患病率的增加、医疗保健意识的提高以及政府的有利举措正在推动全球呼吸道感染治疗市场的增长。
竞争格局和重点公司:
全球呼吸道感染治疗市场预测可以帮助利益相关者规划其增长战略。雅培实验室、阿斯利康公司、Alembic Pharmaceuticals Ltd.、勃林格殷格翰国际有限公司、葛兰素史克公司、梯瓦制药工业有限公司、诺华公司、罗氏公司、赛诺菲公司、默克公司和西普拉是全球呼吸道感染治疗市场报告中介绍的知名企业。这些公司专注于各种战略(包括有机和无机战略),以满足不断增长的消费者需求并扩大其专业产品组合的产品范围。市场公司采用的主要战略包括新技术发布、现有产品开发和地域扩张。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Respiratory diseases such as asthma, bronchitis, allergic rhinitis, pneumonia and sinusitis can seriously impair a person's physical functioning. Symptoms associated with both mild and severe diseases of these respiratory tracts include cough, wheezing, chest pain, difficulty breathing, and shortness of breath, congestion and, in severe cases, even death. These conditions cause significant morbidity and high costs to society. Treatment of the above respiratory disease is known as respiratory tract infection treatment.
The key factors driving the respiratory tract infection treatment market growth are the demand for the diagnosis of respiratory diseases owing to the rising prevalence of these diseases coupled with rising demand for OTC products. In addition, continuous research and development in this field has resulted in various diagnostic tests and procedures that will positively affect the growth of the market in the coming years.
The respiratory tract infection treatment market was valued at US$ 43.60 billion in 2023.
The respiratory tract infection treatment market is expected to be valued at US$ 69.13 billion in 2031.
The respiratory tract infection treatment market has major market players, including Abbott Laboratories, AstraZeneca plc, Alembic Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche AG, Sanofi S.A., Merck & Co and Cipla.
Based on drug, the market is segmented into Antibiotics, NSAIDs, Cough Suppressants, Nasal Decongestants, and Others. The antibiotics segment held the largest respiratory tract infection treatment market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.
Based on disease indication, the respiratory tract infection treatment market is segmented into LRTI and URTI. The LRTI is anticipated to hold a significant share by 2031.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Respiratory Tract Infection Market
- Merck & Co
- Abbott
- AbbVie
- Sanofi
- GlaxoSmithKline plc
- F. Hoffmann La Roche Ltd.
- Pfizer, Inc.
- Novartis AG
- Teva Pharmaceuticals
- Boehringer Ingelheim GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.